Orencia (abatacept) Subcutaneous — Point32Health
Psoriatic Arthritis
Preferred products
- Cimzia
- Enbrel
- Humira
- Simponi
- Yesintek
- Skyrizi
- Taltz
- Tremfya
- Rinvoq
- Xeljanz
Initial criteria
- Documented diagnosis of psoriatic arthritis
- Patient age ≥ 2 years
- Prescribed by or in consultation with a rheumatologist or dermatologist
- Documentation of one (1) of the following: (a) Trial and failure with two (2), or contraindication to all of the following: Cimzia, Enbrel, Humira, Simponi, Yesintek, Skyrizi, Taltz, Tremfya, Rinvoq, Xeljanz; OR (b) The patient is new to the plan and stable on Orencia and the prescribing physician has documented that changing to a preferred product would result in adverse clinical outcomes